Efficacy and Safety of Post-CDK4/6i Treatment Options for HR-Positive, HER2-Negative Advanced Breast Cancer: A Network Meta-Analysis of RCTs

SSRN Electronic Journal 2026 Preprint Open access

Read full text
Authors: J. Wang, Longhu Huang, Yushuai Yu, Ezhang Liu, Qisheng Lin
DOI: 10.2139/ssrn.6213723
Cited by: 0

Fields of Study & Subjects

Advanced Breast Cancer Therapies Breast Cancer Treatment Studies PARP inhibition in cancer therapy

Publication details

Journal / source
SSRN Electronic Journal
Publication date
1 January 2026
Language
EN
Document type
Preprint